A revered clinician and groundbreaking researcher, David Kuter, MD, DPhil, is director of the Center for Hematology at the Mass General Cancer Center. His basic science laboratory was among the first to discover thrombopoietin, which regulates platelet production. His clinical research group has developed new drugs for treating thrombocytopenia. which are now widely used in more than 100 countries. Over the past 30 years he has devoted a large part of his time to the training and education of several generations of hematology fellows.
Dr. Kuter’s patients appreciate his expertise as well as his compassion. Reba Orszag writes, “As my husband’s oncologist-hematologist from 1997 to 2011, Dr. Kuter was so outstanding that we gladly made the 267-mile trip from our home in Princeton, NJ to Mass General. His attention to every aspect of my husband’s struggle reflects his devotion to his patients and his profession.”
“Dr. Kuter was a voice of reason in the midst of chaos,” writes Lisa Gruber, whom Dr. Kuter treated for a rare and serious blood disease. “He not only provided me with excellent care but was supportive throughout my treatment and well beyond my recovery. Dr. Kuter encouraged me to get back to the world of the living, resume the work I love, and enjoy life to the fullest.”
